NBTX — NANOBIOTIX
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 19 SEC-registered investment managers reported holding NBTX (NANOBIOTIX) in their latest 13F filings, with a combined reported value of $218.38M across 5.79M shares. That is +0.2% by share count (+11.70K shares) versus the previous quarter, while reported value moved +22.4%. Ownership is concentrated: the five largest holders account for 99.2% of reported value and the top ten for 99.9%.
Compared with the prior quarter, 7 opened new positions, 6 added to existing stakes, 2 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of NANOBIOTIX (NBTX) include JOHNSON & JOHNSON, Baillie Gifford & Co, Artal Group S.A., ranked by reported 13F value among the 38 institutional holders on this page.
NBTX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 14 | 5.69M | $177.37M | -0.8% |
| Q2 2026 | 19 | 5.79M | $218.38M | +0.2% |
| Q1 2026 | 15 | 5.70M | $175.90M | +0.2% |
| Q4 2025 | 15 | 5.72M | $132.19M | +0.7% |
| Q3 2025 | 11 | 5.64M | $106.63M | -0.1% |
| Q2 2025 | 10 | 5.65M | $25.56M | +0.0% |
| Q1 2025 | 11 | 5.76M | $20.62M | -2.9% |
| Q4 2024 | 18 | 6.08M | $17.46M | -7.2% |
Over the 8 quarters shown, institutional share counts decreased 6% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (-7.2%).
Top Institutional Holders (Q3 2026) — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.62M | $175.24M | 23.01% | Hold | |
| 32.88K | $1.02M | 0.00% | Add | |
| 26.53K | $826.00K | 0.00% | Reduce | |
| 5.04K | $156.98K | 0.00% | Add | |
| 1.30K | $40.47K | 0.00% | Reduce | |
| 1.13K | $35.34K | 0.00% | Add | |
| 735 | $23.15K | 0.00% | Reduce | |
| 504 | $15.71K | 0.00% | Add | |
| 143 | $4.46K | 0.00% | Reduce | |
| 51 | $1.59K | 0.00% | New | |
| 28 | $872 | 0.00% | New | |
| 13 | $406 | 0.00% | New | |
| 11 | $343 | 0.00% | New | |
| 1 | $31 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.62M | $212.02M | 26.55% | Hold | |
| 49.79K | $1.88M | 0.00% | Add | |
| 32.18K | $1.21M | 0.00% | New | |
| 27.33K | $1.03M | 0.00% | New | |
| 15.86K | $597.73K | 0.01% | New | |
| 13.63K | $513.89K | 0.00% | Add | |
| 10.04K | $378.66K | 0.00% | Add | |
| 6.04K | $227.78K | 0.00% | New | |
| 4.04K | $152.46K | 0.00% | Add | |
| 2.58K | $97.15K | 0.00% | Reduce | |
| 2.19K | $83.00K | 0.00% | Add | |
| 1.71K | $61.35K | 0.00% | New | |
| 1.50K | $56.62K | 0.00% | Reduce | |
| 985 | $37.13K | 0.00% | Add | |
| 500 | $18.85K | 0.00% | Hold | |
| 200 | $7.54K | 0.00% | Hold | |
| 76 | $2.87K | 0.00% | New | |
| 56 | $2.11K | 0.00% | New | |
| 13 | $482 | 0.00% | Hold |
Q1 2026 — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.62M | $173.61M | 26.61% | Hold | |
| 36.27K | $1.12M | 0.00% | Add | |
| 13.50K | $416.78K | 0.00% | Reduce | |
| 9.24K | $285.21K | 0.00% | Reduce | |
| 5.56K | $171.54K | 0.00% | Add | |
| 3.56K | $109.87K | 0.00% | Reduce | |
| 2.28K | $70.41K | 0.00% | Reduce | |
| 1.82K | $56.00K | 0.00% | Reduce | |
| 828 | $25.56K | 0.00% | Add | |
| 514 | $15.87K | 0.00% | Hold | |
| 500 | $15.44K | 0.00% | Hold | |
| 200 | $6.17K | 0.00% | Hold | |
| 13 | $394 | 0.00% | Hold | |
| 1 | $31 | 0.00% | New | |
| 1 | $31 | 0.00% | New |
Q4 2025 — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.62M | $130.02M | 23.43% | Hold | |
| 22.92K | $529.98K | 0.00% | Add | |
| 16.87K | $390.01K | 0.00% | New | |
| 16.87K | $390.01K | 0.00% | New | |
| 16.23K | $375.12K | 0.00% | Add | |
| 9.50K | $219.64K | 0.00% | New | |
| 3.60K | $83.23K | 0.00% | Add | |
| 2.62K | $61.00K | 0.00% | Add | |
| 2.34K | $54.14K | 0.00% | Add | |
| 1.53K | $35.37K | 0.00% | Reduce | |
| 514 | $11.88K | 0.00% | Hold | |
| 500 | $11.56K | 0.00% | New | |
| 229 | $5.29K | 0.00% | New | |
| 200 | $4.62K | 0.00% | New | |
| 13 | $300 | 0.00% | Hold |
Q3 2025 — 11 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.62M | $106.23M | 21.08% | Hold | |
| 10.18K | $192.38K | 0.00% | Hold | |
| 5.36K | $101.17K | 0.00% | New | |
| 2.38K | $44.92K | 0.00% | Reduce | |
| 2.16K | $40.82K | 0.00% | Reduce | |
| 514 | $9.71K | 0.00% | Reduce | |
| 400 | $7.56K | 0.00% | Reduce | |
| 125 | $2.00K | 0.00% | Hold | |
| 33 | $623 | 0.00% | Hold | |
| 13 | $245 | 0.00% | Hold | |
| 4 | $76 | 0.00% | Hold |
Q2 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.62M | $25.45M | 7.62% | Hold | |
| 10.18K | $48.17K | 0.00% | Hold | |
| 5.30K | $25.07K | 0.00% | Reduce | |
| 4.42K | $20.90K | 0.00% | Add | |
| 761 | $3.60K | 0.00% | Add | |
| 517 | $2.44K | 0.00% | New | |
| 125 | $1.00K | 0.00% | New | |
| 33 | $156 | 0.00% | Hold | |
| 13 | $61 | 0.00% | New | |
| 4 | $19 | 0.00% | Hold |
New Positions (Q2 2026)
- JANE STREET GROUP, LLC 32.18K sh · $1.21M
- HRT FINANCIAL LP 27.33K sh · $1.03M
- XTX Topco Ltd 15.86K sh · $597.73K
- Citadel Advisors 6.04K sh · $227.78K
- JPMorgan Chase & Co 1.71K sh · $61.35K
- Stone House Investment Management, LLC 76 sh · $2.87K
- Federation des caisses Desjardins du Quebec 56 sh · $2.11K
Fully Exited (vs previous quarter)
- EverSource Wealth Advisors, LLC sold 514 sh · $15.87K
- Citigroup Inc sold 1 sh · $31
- Tower Research Capital LLC (TRC) sold 1 sh · $31
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 5.62M | 5.62M | 5.62M | 5.62M | 5.62M | 5.62M | 5.62M | 5.62M | 5.62M | 5.62M | 5.62M | 5.62M | 959.64K | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 32.88K | 32.18K | — | — | — | — | 11.39K | 23.28K | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 26.53K | 27.33K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 5.04K | 2.58K | 5.56K | 1.53K | 2.16K | 4.42K | 3.00K | 3.82K | 3.10K | 3.10K | 3.10K | 3.10K | 3.81K | 4.00K | 3.00K | 3.80K | 3.04K | 3.04K | 3.82K | 6.01K |
| RHUMBLINE ADVISERS | 1.30K | 1.50K | 2.28K | 2.34K | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | — | — | — | — | — | — | — |
| GAMMA Investing LLC | 1.13K | 985 | 828 | 229 | — | — | — | 154 | 2.86K | 2.03K | 1.15K | 175 | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 735 | 1.71K | — | — | — | — | — | 256 | — | — | — | — | — | 2 | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 504 | 500 | 500 | 500 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 143 | 49.79K | 36.27K | 22.92K | 2.38K | 5.30K | 6.10K | 5.10K | 2 | 2 | 2 | 302 | 1.70K | — | — | — | — | — | — | — |
| LANARK FINANCIAL, INC. | 51 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NISA INVESTMENT ADVISORS, LLC | 28 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Physician Wealth Advisors, Inc. | 13 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 11 | — | — | — | — | — | — | 51.48K | 228.92K | — | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | 1 | — | 1 | — | — | — | 241 | 241 | 3.42K | — | — | 635 | — | — | — | — | — | — | — | — |
| Baillie Gifford & Co | — | — | — | — | — | — | — | — | — | 2.87M | 2.87M | 2.87M | 1.94M | 1.40M | 1.40M | 1.40M | 1.40M | 1.40M | 1.40M | 1.40M |
| Artal Group S.A. | — | — | — | — | — | — | — | — | — | — | — | — | 1.00M | — | — | — | — | — | — | — |
| PERCEPTIVE ADVISORS LLC | — | — | — | — | — | — | 105.05K | 266.09K | 555.07K | 555.07K | 555.07K | 555.07K | 555.07K | — | — | — | — | — | — | — |
| XTX Topco Ltd | — | 15.86K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Optiver Holding B.V. | — | 13.63K | 13.50K | 16.23K | 5.36K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Millennium Management | — | — | — | 16.87K | — | — | — | 13.45K | — | — | — | — | — | — | — | — | — | — | — | 12.22K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold NBTX?
As of 2026-Q2, 19 institutional funds reported holding NBTX (NANOBIOTIX) in SEC 13F filings, with a combined reported value of $218.38M.
How many shares of NBTX do institutions own?
13F filers reported 5.79M shares of NBTX, worth $218.38M in aggregate at the end of 2026-Q2.
Is institutional ownership of NBTX rising or falling?
Share counts moved +0.2% versus the prior quarter — accumulation.
Who are the top institutional holders of NBTX?
The largest 13F holders are JOHNSON & JOHNSON, Baillie Gifford & Co, Artal Group S.A., JANE STREET GROUP, LLC, HRT FINANCIAL LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of NANOBIOTIX?
The major shareholders of NANOBIOTIX (NBTX) by reported 13F value are JOHNSON & JOHNSON, Baillie Gifford & Co, Artal Group S.A., JANE STREET GROUP, LLC, HRT FINANCIAL LP, among 38 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.